Sensei Biotherapeutics, Inc. — All Filings
378 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 SUBMISSION | 0001209191-23-054170 | Nov 2, 2023 | Nov 1, 2023 |
| 3 | FORM 3 SUBMISSION | 0001209191-23-054166 | Nov 2, 2023 | Nov 1, 2023 |
| 8-K | 8-K | 0001193125-23-259994 | Oct 20, 2023 | Oct 17, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-049192 | Sep 13, 2023 | Sep 11, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-048966 | Sep 11, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-048967 | Sep 11, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-048968 | Sep 11, 2023 | Feb 15, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-048965 | Sep 11, 2023 | Feb 15, 2023 |
| 424B5 | 424B5 | 0001193125-23-215140 | Aug 17, 2023 | — |
| SC 13G/A | — | 0000897069-23-001093 | Aug 4, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-038085 | Aug 3, 2023 | Jun 30, 2023 |
| 8-K | 8-K | 0001193125-23-202349 | Aug 3, 2023 | — |
| 4 | — | 0000897069-23-001052 | Aug 2, 2023 | Jul 31, 2023 |
| 4 | — | 0000897069-23-001054 | Aug 2, 2023 | Jul 31, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042102 | Jul 12, 2023 | Jul 10, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042096 | Jul 12, 2023 | Jul 10, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042103 | Jul 12, 2023 | Jul 10, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042076 | Jul 12, 2023 | Jul 10, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042079 | Jul 12, 2023 | Jul 10, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042095 | Jul 12, 2023 | Jul 10, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042101 | Jul 12, 2023 | Jul 10, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042097 | Jul 12, 2023 | Jul 10, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-23-042098 | Jul 12, 2023 | Jul 10, 2023 |
| 8-K | 8-K | 0001193125-23-184650 | Jul 10, 2023 | — |
| 8-K | 8-K | 0001193125-23-175647 | Jun 27, 2023 | — |
| 8-K | 8-K | 0001193125-23-173860 | Jun 23, 2023 | — |
| ARS | ARS | 0000950170-23-028328 | Jun 15, 2023 | Dec 31, 2022 |
| DEF 14A | DEF 14A | 0000950170-23-028311 | Jun 15, 2023 | Jul 10, 2023 |
| SC 13D/A | AMENDMENT NO. 5 TO THE SCHEDULE 13D | 0000921895-23-001419 | Jun 2, 2023 | — |
| 4 | OWNERSHIP DOCUMENT | 0000921895-23-001420 | Jun 2, 2023 | Jun 1, 2023 |
| DEFA14A | DEFA14A | 0001193125-23-151847 | May 23, 2023 | — |
| SC 13D/A | AMENDMENT NO. 4 TO THE SCHEDULE 13D | 0000921895-23-001333 | May 23, 2023 | — |
| 8-K | 8-K | 0001193125-23-151834 | May 23, 2023 | — |
| 10-Q | 10-Q | 0000950170-23-019754 | May 9, 2023 | Mar 31, 2023 |
| 8-K | 8-K | 0001193125-23-138934 | May 9, 2023 | — |
| 10-K/A | 10-K/A | 0000950170-23-016251 | May 1, 2023 | Dec 31, 2022 |
| 8-K | 8-K | 0001193125-23-107449 | Apr 20, 2023 | — |
| 4/A | FORM 4/A SUBMISSION | 0001209191-23-021541 | Mar 29, 2023 | Feb 15, 2023 |
| 4/A | FORM 4/A SUBMISSION | 0001209191-23-021542 | Mar 29, 2023 | Feb 15, 2023 |
| 10-K | 10-K | 0000950170-23-010432 | Mar 29, 2023 | Dec 31, 2022 |
| S-8 | S-8 | 0000950170-23-010649 | Mar 29, 2023 | — |
| 4/A | FORM 4/A SUBMISSION | 0001209191-23-021540 | Mar 29, 2023 | Feb 15, 2023 |
| 8-K | 8-K | 0001193125-23-081485 | Mar 28, 2023 | — |
| 8-K | 8-K | 0001193125-23-068480 | Mar 13, 2023 | — |
| 8-K | 8-K | 0001193125-23-066980 | Mar 10, 2023 | — |
| DEFA14A | DEFA14A | 0001193125-23-066986 | Mar 10, 2023 | — |
| SC 13D/A | AMENDMENT NO. 3 TO THE SCHEDULE 13D | 0000921895-23-000671 | Mar 9, 2023 | — |
| 8-A12B | 8-A12B | 0001193125-23-063093 | Mar 7, 2023 | — |
| 4/A | FORM 4/A | 0001567619-23-004608 | Mar 7, 2023 | Jun 10, 2022 |
| 8-K | 8-K | 0001193125-23-063316 | Mar 7, 2023 | — |